Sign in Create account
Sign in and upgrade to a paid plan to export bulk/block deals as CSV.

Dishman Carbogen Amcis Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: DCAL BSE: 540701
₹157.47
▼ -3.92 (-2.43%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
35/100
Weak
Valuation
100/100
Undervalued
Momentum
11/100
Bearish

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Dishman Carbogen Amcis Ltd is an Indian multinational pharmaceutical company specialized in the manufacture of active ingredients and contract development and manufacturing. Dishman employs over 1,000 people worldwide and is listed on the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE).

Source: Wikipedia

Key Metrics

Market Capitalization
₹2,469 Cr
PE (TTM)
Data unavailable.
Price to Book
0.4
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
8.93%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
-1.1
Relative return vs Sector, qtr %
-10.5
Free Cash Flow
₹225 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-994.12%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
0.00%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-37.16%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
176.95%
as of June 30, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-9.20%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.23
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.42
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
-0.08
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
4.25%
as of June 30, 2025
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-17.50%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-3.14%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
0.82%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
2.91%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
1.46%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.42)
  • No Return on equity is 15% or more (1.5%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.4%
Low 156.3500 · High 163.8300
1W return
-9.2%
Low 156.3500 · High 174.0000
1M return
-11.7%
Low 156.3500 · High 188.0000
52W return
-43.0%
Low 128.5000 · High 306.0000
Lifetime High ₹390.0500 (Jan. 23, 2018)
Lifetime Low ₹48.4500 (March 27, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
162.8
10D
165.3
20D
168.4
50D
174.6
100D
181.0
200D
190.4

Delivery and volume

Day avg. delivery
68.1%
Week avg. delivery
65.3%
Month avg. delivery
45.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

159.22
Pivot
First resistance162.08
Second resistance166.70
Third resistance169.56
First support154.60
Second support151.74
Third support147.12
Day RSI33.0
Day MFI60.0
Day MACD-4.03
Day MACD signal-3.57

Beta

1M1.86
3M1.51
1Y1.83
3Y1.67

Price change analysis

↓ -11.7%
Over 1 Month
LowHigh
156.35188.00
↓ -10.5%
Over 3 Months
LowHigh
156.35204.50
↑ 7.8%
Over 6 Months
LowHigh
139.64224.40
↓ -43.0%
Over 1 Year
LowHigh
128.50306.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹57 Cr
Net profit (June 30, 2026)
₹-24 Cr
Basic EPS (June 30, 2026)
₹-1.5200

Ranks #73 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter59.32%
  • Mutual funds1.41%
  • FII/FPI6.86%
  • Other DII0.66%
  • Public31.75%

Largest holders

NameCategoryShares %Shares
Adimans Technologies LLPPromoter59.3200%93002442
Mukul Mahavir AgrawalPublic5.5000%8617000
Massachusetts Institute Of TechnologyPublic2.2800%3570000
Hbm Healthcare Investments (Cayman) LtdPublic2.1900%3432857
Hsbc Mutual Fund - Hsbc Flexi Cap FundPublic1.4100%2215137

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 59.32% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 7.45% to 6.86% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 1.06% to 1.41% in Jun 2026 qtr

1 mutual fund scheme also holds this stock.

All shareholding details →

Insider trading, SAST & pledges

All 9 insider trades, 7 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
16 Feb 2023 Nikunj Desai Immediate relative Buy 0 ₹0
16 Feb 2023 Nikunj Desai Immediate relative Buy 0 ₹0
16 Jan 2021 Adimans Technologies LLP Promoter Sell 0 ₹0
16 Jan 2021 Adimans Technologies LLP Promoter Sell 0 ₹0
22 Dec 2020 Adimans Technologies LLP Promoter Sell 0 ₹0
22 Dec 2020 Adimans Technologies LLP Promoter Sell 0 ₹0
30 Mar 2020 Himani Sanjay Dhotre Employee / designated person Buy 0 ₹0
1 Feb 2019 Adimans Technologies Private Limited Promoter Sell 0 ₹0
1 Feb 2019 Adimans Technologies LLP Promoter Buy 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 25 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
11 Dec 2024 CRONY VYAPAR PVT LTD Bulk Sell 1,135,435 299.9000 NSE
11 Dec 2024 CRONY VYAPAR PVT LTD Bulk Buy 1,115,624 299.1900 NSE
11 Dec 2024 CRONY VYAPAR PVT LTD Bulk Sell 1,135,435 299.9000 NSE
11 Dec 2024 CRONY VYAPAR PVT LTD Bulk Buy 1,115,624 299.1900 NSE
9 Dec 2024 CRONY VYAPAR PVT LTD Bulk Buy 1,331,863 277.8600 NSE
9 Dec 2024 CRONY VYAPAR PVT LTD Bulk Sell 1,136,974 277.8200 NSE
5 Mar 2024 CRONY VYAPAR PVT LTD Bulk Buy 870,469 276.3300 NSE
5 Mar 2024 CRONY VYAPAR PVT LTD Bulk Sell 856,469 276.7700 NSE
4 Mar 2024 CRONY VYAPAR PVT LTD Bulk Buy 1,024,504 267.8000 NSE
4 Mar 2024 CRONY VYAPAR PVT LTD Bulk Sell 867,097 268.4900 NSE

All bulk and block deals →

Dividends

Full dividend history →
Ex-dateSubjectPer share (₹)Record date
12 Sep 2019 Dividend - Rs 0.20 Per Share 0.2000 —

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
14 Aug 2026 Financial Results Yes
12 Aug 2026 Fund Raising —
19 May 2026 Financial Results/Other business matters Yes
18 Mar 2026 Fund Raising —
3 Feb 2026 Financial Results Yes

Corporate Announcements

All 548 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
2 Oct 2026 Board Meeting Dishman Carbogen Amcis Ltd - 540701 - Board Meeting Intimation for Considering And Approving (A) Fund Raising And (B) Modification/Change In Security In Respect Of NCD Having Scrip Code 978230
1 Oct 2026 AGM/EGM Dishman Carbogen Amcis Ltd - 540701 - Shareholder Meeting / Postal Ballot-Outcome of AGM
1 Oct 2026 Shareholders meeting Dishman Carbogen Amcis Limited has informed the Exchange regarding voting results of Annual General Meeting held on September 30, 2026
30 Sep 2026 AGM/EGM Dishman Carbogen Amcis Ltd - 540701 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 AGM/EGM Dishman Carbogen Amcis Ltd - 540701 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 Shareholders meeting Dishman Carbogen Amcis Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026
30 Sep 2026 Shareholders meeting Dishman Carbogen Amcis Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026
28 Sep 2026 Allotment of Securities Dishman Carbogen Amcis Limited has informed the Exchange regarding allotment of 1500 securities pursuant to Non Convertible Securities at its meeting held on September 28, 2026
28 Sep 2026 Company Update Dishman Carbogen Amcis Ltd - 540701 - Announcement under Regulation 30 (LODR)-Allotment
24 Sep 2026 Trading Window Dishman Carbogen Amcis Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (1.5%)
  • Thin net profit margin (4.2%)
  • Declining revenue YoY (-9.2%)

Opportunities

  • Trading below book value (PB 0.37)

Threats

  • Down 43.0% over the past year
  • Weak interest coverage (-0.1x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Dishman Carbogen Amcis Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.